PROM1 and exstrophy-epispadias complex: The aim of this study was to identify different subtypes of EEC based on the percentage of CD133-expressing cells, to evaluate the impact of CD133 expression on survival of EEC patients and to analyse the correlation of CD133 tumour status with relevant clinic-pathological features.